OASYS NOW
@OASYSNOW
Followers
85
Following
89
Media
3
Statuses
41
Bringing precision medicine to patients faster, by empowering people with control over their data. 🧬🩺🔬
Delft, The Netherlands
Joined February 2021
đź“ŁToday, we're announcing our partnership with Progress Clinical Research and Brain Research Center, the leading drug research institutes in the Netherlands, specializing in a wide range of diseases from #Alzheimer's, #Parkinson's & #Dementia, to #Cardiometabolic and #Immunology.
0
0
1
Every year, the Slush 100 startup competition puts the world’s boldest early-stage companies on stage in front of a 13,000+ hyper-relevant crowd. The winner takes home the €1M investment prize, but even making it to the stage unlocks unique opportunities. Let’s take a look at
0
3
1
How can you make sharing health data as easy as logging onto Spotify? And how can you do this while safeguarding their privacy? In episode 98 of Women Disrupting Tech, @OASYSNOW founders Sara and Nima tell their story: https://t.co/hI3acIV6AU
#WomenDisruptingTech
0
1
1
What if accessing your own health data was as easy as logging into Spotify? In episode 98 of Women Disrupting Tech, Sara Okhuijsen and Nima Salami share how @OASYSNOW is making personalized medicine secure, inclusive, and accessible. Check their story at https://t.co/k59VdkOUZT
0
2
2
We’re proud to see four Slushers on this year’s @Forbes 30 Under 30 Europe list. Shoutout to: 🔹 @ainobergius—CEO at Slush, and a longtime contributor to the ecosystem, starting from volunteering back in 2014. 🔹Mikko Mäntylä—Former President of Slush. Currently building
0
2
6
Most clinical trials fail. Most health data excludes most people. In episode 98 of Women Disrupting Tech, Sara Okhuijsen and Nima Salami share how @oasysnow is building a future where personalized medicine works for everyone. Check out their story at https://t.co/NhWlsvBnJz
0
2
1
🎊Our alumnus @OkhuijsenSara & @EEMCS_TUD alumnus @Nima_Salami won the @SlushHQ startup competition in Helsinki with their startup @OASYSNOW. They aim to enable personalised #healthcare and empower patients to take control of their own data. Congrats! Photo credits: @PetriAPhoto
0
1
2
The partnership between OASYS NOW and Progress Clinical Research exemplifies the transformative power of #AI in #healthcare. By combining our expertise and resources, we are paving the way for a future where clinical trials are more efficient, effective, and accessible to all.
0
0
1
đź“ŁToday, we're announcing our partnership with Progress Clinical Research and Brain Research Center, the leading drug research institutes in the Netherlands, specializing in a wide range of diseases from #Alzheimer's, #Parkinson's & #Dementia, to #Cardiometabolic and #Immunology.
Fresh off its victory at the #Slush 100 competition, where it secured a €1 million equity investment from General Catalyst and Cherry Ventures, #OASYSNOW has announced its partnership with #ProgressClinicalResearch 🇳🇱 🤝 https://t.co/CyUuETVVBL
1
2
3
Congratulations @OASYSNOW for winning the #slush100 #slush2024 pitching and 1 000 000 Eur! The pitch was awesome! Great to see #MyData -aligned solutions in health gaining such great recognition! #personaldata #dataprivacy #dataempowerment
1
2
4
Thank you, @NVIDIAEU! We're a happy NVIDIA Inception member and enjoy the collaboration with your FL and Privacy team!
🎉 Congratulations to NVIDIA Inception member @OASYSNOW on winning the Slush startup competition!👏 Learn about our startup program: https://t.co/TdMHJXxM5i.
@SlushHQ #Slush100 #Slush2024
0
0
2
🎉 Congratulations to NVIDIA Inception member @OASYSNOW on winning the Slush startup competition!👏 Learn about our startup program: https://t.co/TdMHJXxM5i.
@SlushHQ #Slush100 #Slush2024
We’re thrilled to unveil this year’s Slush 100 winner: OASYS NOW OASYS NOW is revolutionizing health tech. Their hard work and vision have won them the grand prize: a €1M equity investment from our esteemed VC partners—General Catalyst and Cherry Ventures. Congratulations
1
3
8
13.000 people in Finnland 🇫🇮, all committed to building the future! 13.000 reasons to be excited and optimistic for European #Tech! Thank you for a great @SlushHQ 2024. Incredible job by the #slush2024 team, especially to the hundreds of volunteers. And CONGRATS to the winners
2
4
21
We’re thrilled to unveil this year’s Slush 100 winner: OASYS NOW OASYS NOW is revolutionizing health tech. Their hard work and vision have won them the grand prize: a €1M equity investment from our esteemed VC partners—General Catalyst and Cherry Ventures. Congratulations
2
8
36
Proud to support this petition for a unified pan-European startup entity. Let’s unite Europe's startup ecosystems! https://t.co/TPIqwcjDwZ 🇪🇺
eu-inc.org
EU–INC is a proposal for a pan-European standardized legal entity to unlock pan-European startup scaling.
0
0
0
We made it to the top 50 of @SlushHQ 100! 🍒Cherry-picked by @CherryVentures and @generalcatalyst! 🎉 On a mission to make Personalized Medicine accessible and equitable to everyone globally!
After much anticipation, the top 50 startups for Slush 100 have been selected. These top startups are transforming industries like deeptech, fintech, medtech, software, and more. But the journey doesn’t stop here—next up is the race to the top 20. The 50 startups will soon
0
0
2
After much anticipation, the top 50 startups for Slush 100 have been selected. These top startups are transforming industries like deeptech, fintech, medtech, software, and more. But the journey doesn’t stop here—next up is the race to the top 20. The 50 startups will soon
1
7
15
We are delighted that so many ambitious startups applied for the first ELSA Open Call! Our five winners have now been announced: @Algomocom, @OASYSNOW, @OttCT, QuantPi and @Sarus_tech will receive funding and work with ELSA on secure AI applications. https://t.co/IhUEHK2DpN
0
4
9
OASYS NOW focusses on developing patient-centric, privacy-first technologies that revolutionize how health data is used in clinical research and healthcare. Read more about @OASYSNOW supported by the first ELSA open call here: https://t.co/0wyTtzzFuK
0
3
7